Preparation of end-capped pH-sensitive mesoporous silica nanocarriers for on-demand drug delivery

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 88, Issue 3, 2014, Pages 1012-1025

  Moreira, André F ^a   Gaspar, Vítor M ^a   Costa, Elisabete C ^a   De Melo Diogo, Duarte ^a   Machado, Paulo ^a   Paquete, Catarina M ^b   Correia, Ilídio J ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

Author keywords

Calcium carbonate; Cancer therapy; Co delivery; Inorganic nanoparticles; pH responsive; Prostate cancer

Indexed keywords

CALCIUM CARBONATE; DOXORUBICIN; IBUPROFEN; MESOPOROUS SILICA NANOPARTICLE; NANOCARRIER; UNCLASSIFIED DRUG; DRUG CARRIER; NANOPARTICLE; SILICON DIOXIDE;

ARTICLE; BIOCOMPATIBILITY; CHEMICAL STRUCTURE; COATED PARTICLE; CYTOTOXICITY; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; PARTICLE SIZE; PH; SYSTEMIC CIRCULATION; THERAPY EFFECT; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; FIBROBLAST; METABOLISM; POROSITY; PROCEDURES; SYNTHESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FIBROBLASTS; HUMANS; HYDROGEN-ION CONCENTRATION; NANOPARTICLES; POROSITY; SILICON DIOXIDE;

EID: 84912574589     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.09.002     Document Type: Article

References (66)

1. A.C. Johnson Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study J. Hydrol. 348 1-2 2008 167 175
2. G. Kibria, H. Hatakeyama, and H. Harashima Cancer multidrug resistance: mechanisms involved and strategies for circumvention using a drug delivery system Arch. Pharm. Res. 37 1 2014 4 15
3. H.H. Duong, and L.Y. Yung Synergistic co-delivery of doxorubicin and paclitaxel using multi-functional micelles for cancer treatment Int. J. Pharm. 454 1 2013 486 495
4. M.J. Piccart-Gebhart Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer J. Clin. Oncol. 26 12 2008 1980 1986
5. J.M. Nabholtz, and A. Riva The choice of adjuvant combination therapies with taxanes: rationale and issues addressed in ongoing studies Clin. Breast Cancer 2 Suppl. 1 2001 S7 S14
6. C. Ferlini Synergistic antiproliferative activity of tamoxifen and docetaxel on three oestrogen receptor-negative cancer cell lines is mediated by the induction of apoptosis Br. J. Cancer 75 6 1997 884 891
7. P. Parhi, C. Mohanty, and S.K. Sahoo Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy Drug Discov. Today 17 17-18 2012 1044 1052
8. J.G. Marques Synthesis and characterization of micelles as carriers of non-steroidal anti-inflammatory drugs (NSAID) for application in breast cancer therapy Colloids Surf. B: Biointerfaces 113 2014 375 383
9. Y. Sun Bioreducible PAA-g-PEG graft micelles with high doxorubicin loading for targeted antitumor effect against mouse breast carcinoma Biomaterials 34 28 2013 6818 6828
10. J. Lu In vivo tumor suppression efficacy of mesoporous silica nanoparticles-based drug-delivery system: enhanced efficacy by folate modification Nanomedicine 8 2 2012 212 220
11. S.R. MacEwan, D.J. Callahan, and A. Chilkoti Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery Nanomedicine 5 5 2010 793 806
12. R. Lehner Designing switchable nanosystems for medical application J. Control. Release 161 2 2012 307 316
13. V.M. Gaspar Biofunctionalized nanoparticles with pH-responsive and cell penetrating blocks for gene delivery Nanotechnology 24 27 2013 275101
14. X. Wang Glutathione-triggered "off-on" release of anticancer drugs from dendrimer-encapsulated gold nanoparticles J. Am. Chem. Soc. 135 26 2013 9805 9810
15. W. Ji Coumarin-containing photo-responsive nanocomposites for NIR light-triggered controlled drug release via a two-photon process J. Mater. Chem. B 1 43 2013 5942 5949
16. N. Mas Enzyme-responsive silica mesoporous supports capped with azopyridinium salts for controlled delivery applications Chemistry 19 4 2013 1346 1356
17. A.S. Wadajkar Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles Biomaterials 34 14 2013 3618 3625
18. A. Honglawan Synthesis of random copolymer based pH-responsive nanoparticles as drug carriers for cancer therapeutics Polym. Chem. 4 13 2013 3667 3675
19. L. Tian, and Y.H. Bae Cancer nanomedicines targeting tumor extracellular pH Colloids Surf. B: Biointerfaces 99 2012 116 126
20. Y. Kato Acidic extracellular microenvironment and cancer Cancer Cell Int. 13 1 2013 89
21. F. Danhier, O. Feron, and V. Preat To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2 2010 135 146
22. Z. Li Mesoporous silica nanoparticles in biomedical applications Chem. Soc. Rev. 41 7 2012 2590 2605
23. E. Aznar Finely tuned temperature-controlled cargo release using paraffin-capped mesoporous silica nanoparticles Angew. Chem. Int. Ed. Engl. 50 47 2011 11172 11175
24. V. Cauda Controlling the delivery kinetics from colloidal mesoporous silica nanoparticles with pH-sensitive gates J. Mater. Chem. 20 21 2010 4305 4311
25. L.S. Wang Biofunctionalized phospholipid-capped mesoporous silica nanoshuttles for targeted drug delivery: improved water suspensibility and decreased nonspecific protein binding ACS Nano 4 8 2010 4371 4379
26. A. Popat A pH-responsive drug delivery system based on chitosan coated mesoporous silica nanoparticles J. Mater. Chem. 22 22 2012 11173 11178
27. K.N. Yang PH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment Cancer Biol. Med. 11 1 2014 34 43
28. Q. Zheng A pH-responsive controlled release system using layered double hydroxide (LDH)-capped mesoporous silica nanoparticles J. Mater. Chem. B 1 11 2013 1644 1648
29. S. Chen Co-delivery of genes and drugs with nanostructured calcium carbonate for cancer therapy RSC Adv. 2 5 2012 1820 1826
30. J. Gu Targeted doxorubicin delivery to liver cancer cells by PEGylated mesoporous silica nanoparticles with a pH-dependent release profile Microporous Mesoporous Mater. 161 2012 160 167
31. K.H. Min The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles Biomaterials 33 23 2012 5788 5797
32. B.V. Parakhonskiy, A. Haase, and R. Antolini Sub-micrometer vaterite containers: synthesis, substance loading, and release Angew. Chem. Int. Ed. 51 5 2012 1195 1197
33. Q. He The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses Biomaterials 31 6 2010 1085 1092
34. C. Charnay Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property Eur. J. Pharm. Biopharm. 57 3 2004 533 540
35. L. Zhang Amphiphilic depsipeptide-based block copolymers as nanocarriers for controlled release of ibuprofen with doxorubicin J. Polym. Sci., Part A: Polym. Chem. 51 15 2013 3213 3226
36. P. Mohan, and N. Rapoport Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking Mol. Pharm. 7 6 2010 1959 1973
37. E.C. Costa Evaluation of nanoparticle uptake in co-culture cancer models PLoS One 8 7 2013 e70072
38. H. Guo Hollow mesoporous silica nanoparticles for intracellular delivery of fluorescent dye Chem. Cent. J. 5 1 2011 1
39. V.M. Gaspar Nanoparticle mediated delivery of pure P53 supercoiled plasmid DNA for gene therapy J. Control. Release 156 2 2011 212 222
40. I.I. Slowing Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers Adv. Drug Deliv. Rev. 60 11 2008 1278 1288
41. M.T. Harris, R.R. Brunson, and C.H. Byers The base-catalyzed hydrolysis and condensation reactions of dilute and concentrated TEOS solutions J. Non-Cryst. Solids 121 1-3 1990 397 403
42. J.M. Rosenholm, C. Sahlgren, and M. Linden Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles - opportunities & challenges Nanoscale 2 10 2010 1870 1883
43. K.-M. Choi, and K. Kuroda Polymorph control of calcium carbonate on the surface of mesoporous silica Cryst. Growth Des. 12 2 2012 887 893
44. A. Shafiu Kamba Biobased calcium carbonate aragonite nanocrystal as a novel anticancer delivery system BioMed. Res. Int. 2013
45. K.K. Coti Mechanised nanoparticles for drug delivery Nanoscale 1 1 2009 16 39
46. S.M. El-Sheikh Effects of cationic surfactant during the precipitation of calcium carbonate nano-particles on their size, morphology, and other characteristics Colloids Surf., A 422 2013 44 49
47. J.M. Morachis, E.A. Mahmoud, and A. Almutairi Physical and chemical strategies for therapeutic delivery by using polymeric nanoparticles Pharmacol. Rev. 64 3 2012 505 519
48. L. Yuan Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery J. Phys. Chem. C 115 20 2011 9926 9932
49. S. Huang Luminescent GdVO4:Eu3+ functionalized mesoporous silica nanoparticles for magnetic resonance imaging and drug delivery Dalton Trans. 42 18 2013 6523 6530
50. C.F. Thorn Doxorubicin pathways: pharmacodynamics and adverse effects Pharmacogenet. Genomics 21 7 2011 440 446
51. J. Andrews Superior effectiveness of ibuprofen compared with other NSAIDs for reducing the survival of human prostate cancer cells Cancer Chemother. Pharmacol. 50 4 2002 277 284
52. R.E. Harris, J. Beebe, and G. Alshafie Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors J. Exp. Pharmacol. 6 2012 491 496
53. R. Jayakumar Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells Carbohydr. Polym. 87 3 2012 2352 2356
54. H. Meng Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line ACS Nano 4 8 2010 4539 4550
55. R. Liu Responsive polymer-coated mesoporous silica as a pH-sensitive nanocarrier for controlled release Langmuir 27 6 2011 3095 3099
56. Q. Liu Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells Int. J. Nanomed. 7 2012 999 1013
57. F. Chen, and Y. Zhu Chitosan enclosed mesoporous silica nanoparticles as drug nano-carriers: sensitive response to the narrow pH range Microporous Mesoporous Mater. 150 2012 83 89
58. S.P. Hudson The biocompatibility of mesoporous silicates Biomaterials 29 30 2008 4045 4055
59. X. Xing Uptake of silica-coated nanoparticles by HeLa cells J. Nanosci. Nanotechnol. 5 10 2005 1688 1693
60. C.J. Ke Real-time visualization of pH-responsive PLGA hollow particles containing a gas-generating agent targeted for acidic organelles for overcoming multi-drug resistance Biomaterials 34 1 2013 1 10
61. A.M. Eckman Drug release patterns and cytotoxicity of PEG-poly(aspartate) block copolymer micelles in cancer cells Pharm. Res. 29 7 2012 1755 1767
62. S.T. Palayoor Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells Clin. Cancer Res. 4 3 1998 763 771
63. S.K. Natarajan, and S. Selvaraj Mesoporous silica nanoparticles: importance of surface modifications and its role in drug delivery RSC Adv. 4 28 2014 14328 14334
64. J. Shen Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism Nanoscale 3 10 2011 4314 4322
65. Y. Gao Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles ACS Nano 5 12 2011 9788 9798
66. D.E. Owens 3rd, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 1 2006 93 102